Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HHS' Thompson Clarifies RU-486 Stance: Is FDA Commissioner In Limbo?

Executive Summary

HHS' interest in the safety of RU-486 does not differ from its interest in the safety of all drug products, HHS Secretary Tommy Thompson maintained during an appearance at the National Press Club April 17.

You may also be interested in...

FDA Efficiency Harmed By Commissioner Confirmation Process – Friedman

FDA would be more effective if the Senate were not required to confirm the commissioner post, former Acting Commissioner Michael Friedman, MD, wrote in an editorial for the Dec. 20 issue of Science

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts